S. 331 · 119th Congress · Crime and Law Enforcement

HALT Fentanyl Act

Permanently schedules fentanyl-related substances as controlled substances. AI-read

Signed into law3.4k words Introduced Jan 30, 2025 · Latest action Jul 16, 2025

How far it has goneBecame law · 6 of 6
  1. IntroducedJan 30, 2025 Done
  2. CommitteeReported Mar 3, 2025 Done
  3. Senate floorPassed 84–⁠16 · Mar 14, 2025 Done
  4. House floorPassed 321–⁠104 · Jun 12, 2025 Done
  5. Chambers agreeIdentical, not needed Not needed
  6. PresidentSigned Jul 16, 2025 Done

What it does

This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the act establishes a new, alternative registration process for certain schedule I research.

The act also makes several other changes to registration requirements for conducting research with controlled substances, including

• permitting a single registration for related research sites in certain circumstances,

• waiving the requirement for a new inspection in certain situations, and

• allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Congressional Research Service · summary of “Public Law” version · Jul 17, 2025

Votes

  1. House · On Passage Jun 12, 2025 · Roll call 166
    321–104Passed
  2. Senate · On Passage of the Bill Mar 14, 2025 · Roll call 127
    84–16Passed
  3. Senate · On the Cloture Motion Mar 13, 2025 · Roll call 124
    84–15Passed
  4. Senate · On Cloture on the Motion to Proceed Mar 6, 2025 · Roll call 110
    82–12Passed

Top row Yea · bottom row NayD left, R right, independents betweenDemocratsRepublicansIndependents

Who lobbies on it

1 organization · 5 filings · Q1 2025–Q3 2026

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. National Fraternal Order of Police 5 of 7 quarters
    “PASSED HOUSE - H.R. 27 (Griffith, R-VA) the Halt All Lethal Trafficking of Fentanyl Act, which would permanently place fentanyl-related substances as a class into schedule I of the Controlled Substances Act. H.R. 378 (Buchanan, R-FL) the Thin Blue Line Act, which would expand the list of aggravating factors in death…”

    Q1 2026 filing · $300K lobbying spend in 2026 to date, all issues

Organizations that named S. 331 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

38 actions · newest first
  1. Jul 16, 2025Became Public Law No: 119-26.
  2. Jul 16, 2025Signed by President.
  3. Jul 8, 2025Presented to President.
  4. Jun 12, 2025Motion to reconsider laid on the table Agreed to without objection.
Show all 38 actionsShow fewer
  1. Jun 12, 2025On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)
  2. Jun 12, 2025Passed/agreed to in House: On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)
  3. Jun 12, 2025Considered as unfinished business. (consideration: CR H2806)
  4. Jun 11, 2025POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
  5. Jun 11, 2025The previous question was ordered pursuant to the rule.
  6. Jun 11, 2025DEBATE - The House proceeded with one hour of debate on S. 331.
  7. Jun 11, 2025Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
  8. Jun 11, 2025Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633)
  9. Jun 10, 2025Rule H. Res. 489 passed House.
  10. Jun 9, 2025Rules Committee Resolution H. Res. 489 Reported to House. Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
  11. Mar 18, 2025Held at the desk.
  12. Mar 18, 2025Received in the House.
  13. Mar 14, 2025Message on Senate action sent to the House.
  14. Mar 14, 2025Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.
  15. Mar 14, 2025Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 84 - 16. Record Vote Number: 127.
  16. Mar 14, 2025The committee substitute agreed to by Unanimous Consent.
  17. Mar 14, 2025Considered by Senate. (consideration: CR S1762-1765)
  18. Mar 13, 2025Considered by Senate. (consideration: CR S1735)
  19. Mar 13, 2025Cloture on the measure invoked in Senate by Yea-Nay Vote. 84 - 15. Record Vote Number: 124. (CR S1735)
  20. Mar 11, 2025Cloture motion on the measure presented in Senate. (CR S1659)
  21. Mar 11, 2025Considered by Senate. (consideration: CR S1659)
  22. Mar 10, 2025Measure laid before Senate by motion.
  23. Mar 10, 2025Motion to proceed to consideration of measure agreed to in Senate by Voice Vote. (consideration: CR S1623)
  24. Mar 10, 2025Motion to proceed to measure considered in Senate. (CR S1623)
  25. Mar 6, 2025Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 82 - 12. Record Vote Number: 110. (CR S1596)
  26. Mar 6, 2025Motion to proceed to measure considered in Senate. (CR S1596)
  27. Mar 5, 2025Motion to proceed to measure considered in Senate. (CR S1521)
  28. Mar 4, 2025Cloture motion on the motion to proceed to the measure presented in Senate. (CR S1488)
  29. Mar 4, 2025Motion to proceed to consideration of measure made in Senate. (CR S1488)
  30. Mar 3, 2025Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
  31. Mar 3, 2025Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
  32. Feb 27, 2025Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
  33. Jan 30, 2025Read twice and referred to the Committee on the Judiciary.
  34. Jan 30, 2025Introduced in Senate

What members said about it

  • Statement · Press release · Sep 16, 2026 · Riley D-NY

    HOUSE PASSES RILEY BILL TO CRACK DOWN ON “TRANQ,” THE DEADLY SEDATIVE MAKING FENTANYL EVEN MORE LETHAL

    Bipartisan legislation gives law enforcement new tools against xylazine traffickers while protecting veterinarians, farmers, and ranchers WASHINGTON, D.C. — The House of Representatives has unanimously passed the bipartisan Combating…

    “I’ve sat with too many parents in Upstate New York who lost a child to an overdose, and I will never forget their faces.”
  • Statement · Press release · Jul 10, 2026 · Heinrich D-NM

    Heinrich, Cassidy, King Press DOJ on Status of Bipartisan HALT Fentanyl Act After Agency Misses Key Implementation Deadline

    U.S. Senators Martin Heinrich (D-N.M.), Bill Cassidy (R-La.), and Angus King (I-Maine) sent a letter pressing Acting Attorney General Todd Blanche on the U.S. Department of Justice’s (DOJ) failure to meet a deadline to implement key…

    “We recognize the importance of maintaining appropriate controls over Schedule I substances while supporting and accelerating research that may lead to new scientific discoveries and the development of new therapeutics.”
  • Statement · Press release · Dec 23, 2025 · Scalise R-LA

    Scalise’s End-of-Year Recap: One Year of Republicans Delivering on our Promises

    We quickly enacted key provisions of the America First agenda, passing legislation to codify 70 of President Trump’s Executive Orders, and had 61 bills signed into law, including 22 CRAs – the most CRAs signed into law by any Congress – to…

    “These are just a few ways House Republicans have delivered for the American people this year and followed through on our promises – and we’re far from done. Next year, we will continue working with President Trump to carry out his America First agenda and achieve real, commonsense wins. House Republicans won’t stop…”
  • Statement · Press release · Jul 28, 2025 · Scalise R-LA

    Scalise’s Summer Update: Six Months of Winning for the American People

    In just over six months, Congressional Republicans and President Trump have united to fulfill these promises and deliver for hardworking Americans.

    “Throughout this Congress, House Republicans have also advanced legislation to support small businesses, crack down on sanctuary cities, combat illegal alien crime, support our men and women in law enforcement, and make the United States the world leader in crypto – and we aren’t stopping there. We won’t stop fighting…”
  • Statement · Press release · Jun 27, 2025 · Schmidt R-KS

    Schmidt, Congress Take Strong Step Forward in Fight Against Opioid Crisis

    Congressman Schmidt (KS-02) today released the following statement celebrating Congress’s recent passage of the HALT Fentanyl Act.

    “As Kansas’s top law enforcement official for more than a decade, I saw firsthand the devastation fentanyl wreaks on our communities.”
  • Statement · Press release · Jun 26, 2025 · LaLota R-NY

    LaLota Votes to Crack Down on Fentanyl Trafficking, Protect Long Island Families

    Congressman Nick LaLota (Suffolk County, NY) released the following statement after voting to pass S. 331, the bipartisan Halt All Lethal Trafficking (HALT) of Fentanyl Act, making fentanyl-related substances permanently classified as…

    “Fentanyl is killing Americans at an alarming rate, and too many Long Island families have felt the devastating impact firsthand. That’s fwhy I proudly voted for S. 331, the Senate’s bipartisan version of the HALT Fentanyl Act—because we need strong, unified action to combat this crisis.”
  • Statement · Press release · Jun 16, 2025 · Davis D-NC

    Congressman Davis Votes for to Protect Eastern NC from Lethal Drugs

    Congressman Don Davis (NC-01) voted for a third time to support a version of S. 331, the Halt All Lethal Trafficking of (HALT) Fentanyl Act, which passed the House by a margin of 321-104.

    “We must continue taking action to stop fentanyl and other illegal drugs from infiltrating our communities across eastern North Carolina and America.”
  • Statement · Press release · Jun 13, 2025 · Arrington R-TX

    Arrington Fights to Defend Our Communities from Fentanyl

    Today, House Budget Chairman Jodey Arrington (TX-19) celebrated the passing of S.331, the Halt All Lethal Trafficking (HALT) of Fentanyl Act, legislation to permanently place fentanyl on Schedule 1 of the Controlled Substances Act (CSA) –…

    “The Biden administration’s surrender of our southern border to narco-terrorists drug cartels fueled the invasion of drugs, crime, and criminals into our communities.”
  • Statement · Press release · Jun 12, 2025 · Bishop D-GA

    CONGRESSMAN BISHOP & BLUE DOG COALITION HELP LEAD CONGRESSIONAL ACTION ON FENTANYL CRISIS

    Congressman Sanford D. Bishop, Jr. (GA-02) supported the passage of S. 331, the HALT Fentanyl Act.

    “Fentanyl continues to hurt communities across America and tear apart families. This bill helps in our fight against this public health emergency and threat to our national security.”
  • Statement · Press release · Jun 12, 2025 · Hayes D-CT

    Hayes Statement on Upcoming Vote for S. 331, the HALT Fentanyl Act

    Today, Congresswoman Jahana Hayes (CT-05) issued the following statement on the upcoming House floor vote on S.331, the HALT Fentanyl Act.

    “For these reasons, I will be voting no once again against the HALT Fentanyl Act, and I encourage my Democratic colleagues to do the same for the sake of our nation and the American people.”
  • Statement · Press release · Jun 12, 2025 · Moore R-WV

    Rep. Moore Votes for HALT Fentanyl Act, Bill Headed to President’s Desk

    Earlier today, the House of Representatives passed S. 331 – the HALT Fentanyl Act, which permanently classifies fentanyl and fentanyl related substances as Schedule 1 under the Controlled Substances Act.

    “Fentanyl has claimed thousands of lives in West Virginia, and the crisis continues to present major challenges for officials on the ground.”
  • Statement · Press release · Mar 17, 2025 · Reed D-RI

    Reed Votes for HALT Fentanyl Act to Keep Fentanyl A Schedule I Drug & Help Curb Trafficking, Overdoses and Deaths

    The U.S. Senate voted 84-16 to pass a bipartisan bill last week that will permanently classify fentanyl-related substances, or ‘copycat’ fentanyl knock-offs, as Schedule I substances under the Controlled Substances Act.

    “I voted for the HALT Fentanyl Act to help save lives and close loopholes that cartels and drug smugglers have exploited to flood our communities with deadly fentanyl and fentanyl copycats. This isn’t about going after low-level dealers or putting more people in jail. Rather, it gives law enforcement the tools they need…”
  • Statement · Press release · Mar 14, 2025 · Hyde-Smith R-MS

    HYDE-SMITH VOTES TO KEEP FENTANYL A SCHEDULE I DRUG TO CURB OVERDOSES, DEATHS

    U.S. Senator Cindy Hyde-Smith (R-Miss.) today joined her Senate colleagues in passing bipartisan legislation to ensure law enforcement and prosecutors continue to have a key tool needed to combat the scourge of crime, overdoses, and deaths…

    “It is absolutely vital that we keep fentanyl permanently classified as a dangerous drug, subject to tight control and serious punishment. The open border policies of the Biden years fueled a surge in fentanyl-related crime and deaths in Mississippi and across the nation. This legislation will ensure that we don’t let…”
  • Statement · Press release · Mar 14, 2025 · Hyde-Smith R-MS

    Senate passes act making fentanyl a permanent Schedule I drug

    Smith of Mississippi joined her colleagues in the Senate to pass a bipartisan bill aimed at combating fentanyl-related crime and overdoses.

    “It is absolutely vital that we keep fentanyl permanently classified as a dangerous drug, subject to tight control and serious punishment.”
  • Statement · Press release · Mar 6, 2025 · Grassley R-IA

    What They Are Saying: Over One Million Law Enforcement Officers Call for Immediate, Clean Senate Passage of HALT Fentanyl Act

    Major law enforcement organizations representing over 1,000,000 officers nationwide, are calling on the Senate to pass the Halt All Lethal Trafficking of (HALT) Fentanyl Act immediately and without amendments.

    “Time is of the essence. The DEA’s temporary authority to schedule all fentanyl-related substances as Schedule I drugs under the Controlled Substances Act ends on March 31… We supported the technical changes that had to be made when the Judiciary Committee approved the manager’s amendment last week, but otherwise urged…”